Harvard T.H.Chan School of Public Health News — Cuba’s ability to develop homegrown COVID-19 vaccines and immunize most of its citizens should serve as a model for developing countries around the world dealing with public health emergencies, according to a new report.

The report was issued October 31 by the first U.S.-led scientific delegation to visit Cuba in five years. The delegation was organized by MEDICC (Medical Education Cooperation with Cuba), a U.S.-based non-profit promoting health-related dialogue and collaboration….

The report called for greater engagement with Cuba’s biotech sector, in spite of political challenges, to bolster the global fight against existing and emerging threats and to support equitable access… 

— Read More —